260 related articles for article (PubMed ID: 20462423)
1. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.
Zhao T; Liu Y
BMC Microbiol; 2010 May; 10():140. PubMed ID: 20462423
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibitory activity of N-acetylcysteine on tympanostomy tube biofilms from methicillin-resistant Staphylococcus aureus and quinolone-resistant Pseudomonas aeruginosa.
Jun Y; Youn CK; Jo ER; Cho SI
Int J Pediatr Otorhinolaryngol; 2019 Nov; 126():109622. PubMed ID: 31404783
[TBL] [Abstract][Full Text] [Related]
3. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
4. Activity of Sodium Lauryl Sulfate, Rhamnolipids, and
Shen Y; Li P; Chen X; Zou Y; Li H; Yuan G; Hu H
Microb Drug Resist; 2020 Mar; 26(3):290-299. PubMed ID: 31211651
[TBL] [Abstract][Full Text] [Related]
5. Activity of
Valzano F; Boncompagni SR; Micieli M; Di Maggio T; Di Pilato V; Colombini L; Santoro F; Pozzi G; Rossolini GM; Pallecchi L
Microbiol Spectr; 2022 Aug; 10(4):e0100622. PubMed ID: 35735984
[TBL] [Abstract][Full Text] [Related]
6. Effect of ciprofloxacin and N-acetylcysteine on bacterial adherence and biofilm formation on ureteral stent surfaces.
El-Feky MA; El-Rehewy MS; Hassan MA; Abolella HA; Abd El-Baky RM; Gad GF
Pol J Microbiol; 2009; 58(3):261-7. PubMed ID: 19899620
[TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine eradicates Pseudomonas aeruginosa biofilms in bone cement.
Onger ME; Gocer H; Emir D; Kaplan S
Scanning; 2016 Nov; 38(6):766-770. PubMed ID: 27186786
[TBL] [Abstract][Full Text] [Related]
8. Evolution of Antibiotic Resistance in Biofilm and Planktonic Pseudomonas aeruginosa Populations Exposed to Subinhibitory Levels of Ciprofloxacin.
Ahmed MN; Porse A; Sommer MOA; Høiby N; Ciofu O
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760140
[TBL] [Abstract][Full Text] [Related]
9. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms.
Haagensen J; Verotta D; Huang L; Engel J; Spormann AM; Yang K
J Antimicrob Chemother; 2017 Dec; 72(12):3357-3365. PubMed ID: 28961810
[TBL] [Abstract][Full Text] [Related]
11. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
Riera E; Macià MD; Mena A; Mulet X; Pérez JL; Ge Y; Oliver A
J Antimicrob Chemother; 2010 Jul; 65(7):1399-404. PubMed ID: 20435779
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
Tewes F; Bahamondez-Canas TF; Smyth HDC
AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
[TBL] [Abstract][Full Text] [Related]
13. The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa.
Shi N; Gao Y; Yin D; Song Y; Kang J; Li X; Zhang Z; Feng X; Duan J
Microb Pathog; 2019 Dec; 137():103765. PubMed ID: 31586475
[TBL] [Abstract][Full Text] [Related]
14. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
[TBL] [Abstract][Full Text] [Related]
15. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
Gupta S; Agarwal S; Sahoo DR; Muralidharan S
Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
Ahire JJ; Neveling DP; Hattingh M; Dicks LM
PLoS One; 2015; 10(4):e0123648. PubMed ID: 25853255
[TBL] [Abstract][Full Text] [Related]
17. Real-Time Monitoring of
Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
[TBL] [Abstract][Full Text] [Related]
18.
Pinto RM; Monteiro C; Costa Lima SA; Casal S; Van Dijck P; Martins MCL; Nunes C; Reis S
ACS Appl Mater Interfaces; 2021 Sep; 13(36):42329-42343. PubMed ID: 34464076
[TBL] [Abstract][Full Text] [Related]
19. Role of antibiofilm-antimicrobial agents in controlling device-related infections.
Aslam S; Darouiche RO
Int J Artif Organs; 2011 Sep; 34(9):752-8. PubMed ID: 22094553
[TBL] [Abstract][Full Text] [Related]
20. Sub-minimum inhibitory concentrations of ceftazidime inhibit Pseudomonas aeruginosa biofilm formation.
Otani S; Hiramatsu K; Hashinaga K; Komiya K; Umeki K; Kishi K; Kadota JI
J Infect Chemother; 2018 Jun; 24(6):428-433. PubMed ID: 29449129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
